Filing Details
- Accession Number:
- 0001179110-14-009327
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-29 13:27:37
- Reporting Period:
- 2014-05-27
- Filing Date:
- 2014-05-29
- Accepted Time:
- 2014-05-29 13:27:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1203343 | Dave Wentz | 3838 West Parkway Blvd Salt Lake City UT 84120 | C.e.o. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-27 | 1,800 | $35.47 | 475,755 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-05-27 | 1,800 | $73.03 | 473,955 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-05-28 | 3,341 | $35.47 | 477,296 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-05-28 | 3,341 | $73.02 | 473,955 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2014-05-27 | 3,502 | $0.00 | 3,502 | $35.47 |
Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2014-05-28 | 6,498 | $0.00 | 6,498 | $35.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
56,498 | 2014-04-27 | 2015-10-27 | No | 4 | M | Direct |
50,000 | 2014-04-27 | 2015-10-27 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II.
- Weighted average price. Price range in multiple transactions was $73.00 to $73.10, inclusive.
- Weighted average price. Price range in multiple transactions was $73.00 to $73.05, inclusive.